223 related articles for article (PubMed ID: 15073049)
1. Enhanced expression of 14-3-3sigma in pancreatic cancer and its role in cell cycle regulation and apoptosis.
Guweidhi A; Kleeff J; Giese N; El Fitori J; Ketterer K; Giese T; Büchler MW; Korc M; Friess H
Carcinogenesis; 2004 Sep; 25(9):1575-85. PubMed ID: 15073049
[TBL] [Abstract][Full Text] [Related]
2. Loss of ONECUT1 expression in human pancreatic cancer cells.
Jiang X; Zhang W; Kayed H; Zheng P; Giese NA; Friess H; Kleeff J
Oncol Rep; 2008 Jan; 19(1):157-63. PubMed ID: 18097590
[TBL] [Abstract][Full Text] [Related]
3. Uroguanylin inhibits proliferation of pancreatic cancer cells.
Kloeters O; Friess H; Giese N; Buechler MW; Cetin Y; Kulaksiz H
Scand J Gastroenterol; 2008; 43(4):447-55. PubMed ID: 18365910
[TBL] [Abstract][Full Text] [Related]
4. Localization of the human hedgehog-interacting protein (Hip) in the normal and diseased pancreas.
Kayed H; Kleeff J; Esposito I; Giese T; Keleg S; Giese N; Büchler MW; Friess H
Mol Carcinog; 2005 Apr; 42(4):183-92. PubMed ID: 15754313
[TBL] [Abstract][Full Text] [Related]
5. The G691S RET polymorphism increases glial cell line-derived neurotrophic factor-induced pancreatic cancer cell invasion by amplifying mitogen-activated protein kinase signaling.
Sawai H; Okada Y; Kazanjian K; Kim J; Hasan S; Hines OJ; Reber HA; Hoon DS; Eibl G
Cancer Res; 2005 Dec; 65(24):11536-44. PubMed ID: 16357163
[TBL] [Abstract][Full Text] [Related]
6. Decreased expression and promoter methylation of the menin tumor suppressor in pancreatic ductal adenocarcinoma.
Cavallari I; Silic-Benussi M; Rende F; Martines A; Fogar P; Basso D; Vella MD; Pedrazzoli S; Herman JG; Chieco-Bianchi L; Esposito G; Ciminale V; D'Agostino DM
Genes Chromosomes Cancer; 2009 May; 48(5):383-96. PubMed ID: 19170121
[TBL] [Abstract][Full Text] [Related]
7. The clinicopathological and prognostic impact of 14-3-3 sigma expression on vulvar squamous cell carcinomas.
Wang Z; Tropè CG; Suo Z; Trøen G; Yang G; Nesland JM; Holm R
BMC Cancer; 2008 Oct; 8():308. PubMed ID: 18950492
[TBL] [Abstract][Full Text] [Related]
8. Effects of bone sialoprotein on pancreatic cancer cell growth, invasion and metastasis.
Kayed H; Kleeff J; Keleg S; Felix K; Giese T; Berger MR; Büchler MW; Friess H
Cancer Lett; 2007 Jan; 245(1-2):171-83. PubMed ID: 16488077
[TBL] [Abstract][Full Text] [Related]
9. Over-expression of S100A2 in pancreatic cancer correlates with progression and poor prognosis.
Ohuchida K; Mizumoto K; Miyasaka Y; Yu J; Cui L; Yamaguchi H; Toma H; Takahata S; Sato N; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
J Pathol; 2007 Nov; 213(3):275-82. PubMed ID: 17940995
[TBL] [Abstract][Full Text] [Related]
10. 14-3-3sigma is down-regulated in human prostate cancer.
Urano T; Takahashi S; Suzuki T; Fujimura T; Fujita M; Kumagai J; Horie-Inoue K; Sasano H; Kitamura T; Ouchi Y; Inoue S
Biochem Biophys Res Commun; 2004 Jul; 319(3):795-800. PubMed ID: 15184053
[TBL] [Abstract][Full Text] [Related]
11. Prostate cancer is characterized by epigenetic silencing of 14-3-3sigma expression.
Lodygin D; Diebold J; Hermeking H
Oncogene; 2004 Dec; 23(56):9034-41. PubMed ID: 15489902
[TBL] [Abstract][Full Text] [Related]
12. Blocking angiotensin II Type 1 receptor triggers apoptotic cell death in human pancreatic cancer cells.
Gong Q; Davis M; Chipitsyna G; Yeo CJ; Arafat HA
Pancreas; 2010 Jul; 39(5):581-94. PubMed ID: 20118823
[TBL] [Abstract][Full Text] [Related]
13. Stat3 and NF-kappaB activation prevents apoptosis in pancreatic carcinogenesis.
Greten FR; Weber CK; Greten TF; Schneider G; Wagner M; Adler G; Schmid RM
Gastroenterology; 2002 Dec; 123(6):2052-63. PubMed ID: 12454861
[TBL] [Abstract][Full Text] [Related]
14. Apoptosis and expression of the Bcl-2 family of proteins and P53 in human pancreatic ductal adenocarcinoma.
Chen D; Zheng X; Kang D; Yan B; Liu X; Gao Y; Zhang K
Med Princ Pract; 2012; 21(1):68-73. PubMed ID: 22024503
[TBL] [Abstract][Full Text] [Related]
15. Expression analysis of PMP22/Gas3 in premalignant and malignant pancreatic lesions.
Li J; Kleeff J; Esposito I; Kayed H; Felix K; Giese T; Büchler MW; Friess H
J Histochem Cytochem; 2005 Jul; 53(7):885-93. PubMed ID: 15995147
[TBL] [Abstract][Full Text] [Related]
16. Correlation between ECT2 gene expression and methylation change of ECT2 promoter region in pancreatic cancer.
Zhang ML; Lu S; Zhou L; Zheng SS
Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):533-8. PubMed ID: 18842503
[TBL] [Abstract][Full Text] [Related]
17. Utilizing quantitative polymerase chain reaction to evaluate prostate stem cell antigen as a tumor marker in pancreatic cancer.
Grubbs EG; Abdel-Wahab Z; Tyler DS; Pruitt SK
Ann Surg Oncol; 2006 Dec; 13(12):1645-54. PubMed ID: 16957968
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of MIF leads to cell cycle arrest and apoptosis in pancreatic cancer cells.
Denz A; Pilarsky C; Muth D; Rückert F; Saeger HD; Grützmann R
J Surg Res; 2010 May; 160(1):29-34. PubMed ID: 19726058
[TBL] [Abstract][Full Text] [Related]
19. In vitro modeling of human pancreatic duct epithelial cell transformation defines gene expression changes induced by K-ras oncogenic activation in pancreatic carcinogenesis.
Qian J; Niu J; Li M; Chiao PJ; Tsao MS
Cancer Res; 2005 Jun; 65(12):5045-53. PubMed ID: 15958547
[TBL] [Abstract][Full Text] [Related]
20. Differential cell cycle and proliferation marker expression in ductal pancreatic adenocarcinoma and pancreatic intraepithelial neoplasia (PanIN).
Karamitopoulou E; Zlobec I; Tornillo L; Carafa V; Schaffner T; Brunner T; Borner M; Diamantis I; Zimmermann A; Terracciano L
Pathology; 2010 Apr; 42(3):229-34. PubMed ID: 20350215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
